Handelsbanken Fonder’s Kyntra Bio KYNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-724
| Closed | -$16K | – | 1574 |
|
|
2023
Q3 | $16K | Hold |
724
| – | – | ﹤0.01% | 1562 |
|
|
2023
Q2 | $49K | Hold |
724
| – | – | ﹤0.01% | 1564 |
|
|
2023
Q1 | $338K | Hold |
724
| – | – | ﹤0.01% | 1220 |
|
|
2022
Q4 | $290K | Hold |
724
| – | – | ﹤0.01% | 1270 |
|
|
2022
Q3 | $235K | Hold |
724
| – | – | ﹤0.01% | 1380 |
|
|
2022
Q2 | $191K | Sell |
724
-188
| -21% | -$48K | ﹤0.01% | 1503 |
|
|
2022
Q1 | $274K | Hold |
912
| – | – | ﹤0.01% | 1551 |
|
|
2021
Q4 | $321K | Buy |
912
+144
| +19% | +$44.8K | ﹤0.01% | 1594 |
|
|
2021
Q3 | $196K | Hold |
768
| – | – | ﹤0.01% | 1657 |
|
|
2021
Q2 | $511K | Buy |
768
+144
| +23% | +$83K | ﹤0.01% | 1366 |
|
|
2021
Q1 | $541K | Sell |
624
-4,240
| -87% | -$4.51M | ﹤0.01% | 1156 |
|
|
2020
Q4 | $4.51M | Hold |
4,864
| – | – | 0.03% | 429 |
|
|
2020
Q3 | $5M | Buy |
4,864
+104
| +2% | +$112K | 0.04% | 372 |
|
|
2020
Q2 | $4.82M | Buy |
4,760
+1,320
| +38% | +$1.23M | 0.04% | 351 |
|
|
2020
Q1 | $2.99M | Buy |
3,440
+800
| +30% | +$795K | 0.06% | 153 |
|
|
2019
Q4 | $2.83M | Sell |
2,640
-5,200
| -66% | -$5.31M | 0.05% | 170 |
|
|
2019
Q3 | $7.25M | Sell |
7,840
-1,200
| -13% | -$1.32M | 0.15% | 136 |
|
|
2019
Q2 | $10.2M | Sell |
9,040
-1,600
| -15% | -$1.75M | 0.19% | 130 |
|
|
2019
Q1 | $14.5M | Sell |
10,640
-3,256
| -23% | -$4.42M | 0.28% | 90 |
|
|
2018
Q4 | $16.1M | Buy |
13,896
+6,296
| +83% | +$7.08M | 0.32% | 86 |
|
|
2018
Q3 | $11.5M | Buy |
7,600
+720
| +10% | +$1.11M | 0.22% | 115 |
|
|
2018
Q2 | $10.8M | Buy |
6,880
+240
| +4% | +$313K | 0.21% | 120 |
|
|
2018
Q1 | $7.67M | Buy |
6,640
+80
| +1% | +$105K | 0.15% | 128 |
|
|
2017
Q4 | $7.77M | Sell |
6,560
-1,400
| -18% | -$1.76M | 0.17% | 110 |
|
|
2017
Q3 | $10.7M | Sell |
7,960
-1,600
| -17% | -$1.69M | 0.25% | 94 |
|
|
2017
Q2 | $7.72M | Hold |
9,560
| – | – | 0.2% | 108 |
|
|
2017
Q1 | $5.89M | Buy |
9,560
+1,600
| +20% | +$974K | 0.16% | 110 |
|
|
2016
Q4 | $4.26M | Hold |
7,960
| – | – | 0.13% | 116 |
|
|
2016
Q3 | $4.12M | Buy |
7,960
+5,600
| +237% | +$2.64M | 0.12% | 125 |
|
|
2016
Q2 | $968K | Buy |
2,360
+560
| +31% | +$256K | 0.04% | 126 |
|
|
2016
Q1 | $958K | Sell |
1,800
-1,400
| -44% | -$698K | 0.04% | 130 |
|
|
2015
Q4 | $2.44M | Buy |
+3,200
| New | +$2.12M | 0.05% | 305 |
|
Other funds holding KYNB
AC
Handelsbanken Fonder's KYNB Position: Q4 2023 in Review
Handelsbanken Fonder sold out of Kyntra Bio (KYNB) in Q4 2023, closing a stake of 724 shares — an estimated $16K sold.
Handelsbanken Fonder first reported a position in KYNB in Q4 2015 and held it in 32 quarters. The position peaked at $16.1M in Q4 2018. 100 funds tracked by Wall St. Rank hold KYNB as of Q4 2023.
- Handelsbanken Fonder reported no remaining Kyntra Bio position as of Q4 2023 after selling out during the quarter.
- Handelsbanken Fonder sold 724 Kyntra Bio shares in Q4 2023, an estimated $16K.
- Handelsbanken Fonder first reported a position in Kyntra Bio in Q4 2015 and held it in 32 quarters.
- Handelsbanken Fonder's Kyntra Bio position peaked at $16.1M in Q4 2018.
- 100 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2023.
Based on Handelsbanken Fonder's 13F filing for Q4 2023, filed 1 Feb 2024.